NCT06155123View on ClinicalTrials.gov

HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

September 1, 2023

Study Completion Date

June 30, 2024

Conditions
Migraine DisordersChronic MigraineEpisodic Migraine
Interventions
DRUG

Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)

Monthly or quarterly mAbs administration for a year

Trial Locations (1)

27100

RECRUITING

Headache Science & Neurorehabilitation Center, Pavia

All Listed Sponsors
lead

"IRCCS National Neurological Institute C. Mondino Foundation"

OTHER